FIELD: medicine.
SUBSTANCE: method involves determining risk groups by evaluating left ventricle output fraction, ventricular disorders of various severity degree and prescribing to each patient group standard drug therapy comprising beta-blockers, disaggregants, angiotensin-converting enzyme inhibitors, statins. Late ventricular potentials, recurrent myocardial infarction and left ventricle aneurysm presence. The following risk groups are defined: of very high risk level - I, of high risk level - II, of increased risk level - III, of moderate risk level - IV, of low risk level - V.
EFFECT: reduced mortality rate.
4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING ARHYTHMOGENIC ACTION OF CARDIAC GLYCOSIDES | 2000 |
|
RU2226068C2 |
METHOD FOR PREDICTING MALIGNANT VENTRICULAR RHYTHM DISORDERS IN POST-INFARCTION CARDIOSCLEROSIS PERIOD AT EARLY STAGE | 2004 |
|
RU2266042C2 |
METHOD FOR PREDICTION OF ISCHEMIC VASCULAR EVENTS IN PATIENTS WITH EXTRASYSTOLE IN AMOUNT OF 700 AND MORE PER DAY | 2023 |
|
RU2824273C1 |
METHOD FOR TREATING VENTRICULAR EXTRASYSTOLE THE CASES OF MYOCARDIAL INFARCTION | 2000 |
|
RU2197241C2 |
METHOD FOR DIAGNOSTICS OF ELECTRIC MYOCARDIAL INSTABILITY | 1999 |
|
RU2208381C2 |
FORECASTING METHOD OF CORONARY HEART DISEASE COURSE | 2008 |
|
RU2391044C2 |
METHOD FOR PREDICTION OF DEVELOPING LIFE-THREATENING VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH NO STRUCTURAL CARDIAC CHANGES | 2011 |
|
RU2456019C1 |
METHOD OF ASSESSING THE REHABILITATION POTENTIAL OF A PATIENT WHO UNDERWENT CORONARY ARTERY STENTING IN THE ACUTE PERIOD OF MYOCARDIAL INFARCTION | 2022 |
|
RU2803005C1 |
METHOD FOR PREDICTING SUDDEN DEATH RISK AFTER MYOCARDIAL INFARCTION | 2002 |
|
RU2217044C1 |
METHOD OF LIFE-THREATENING VENTRICULAR ARRHYTHMIA PROGNOSIS FOR PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | 2009 |
|
RU2438562C2 |
Authors
Dates
2006-01-20—Published
2004-04-26—Filed